| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Arteriosclerosis and Thrombosis, Vol 14, 753-759, Copyright © 1994 by American Heart Association
ARTICLES |
AJ Cayatte, JJ Palacino, K Horten and RA Cohen
Robert Dawson Evans Department of Clinical Research, Boston University School of Medicine, Mass. 02118.
To determine if endogenous local levels of nitric oxide (NO) modulate atherogenesis, we studied the effect of inhibiting NO with NG-nitro-L- arginine methyl ester (L-NAME) on early neointima formation in cholesterol-fed rabbits. Male rabbits were fed for 5 weeks with a 0.5% cholesterol diet alone or treated in addition during the last 4 weeks with L-NAME (12 mg/kg per day SC) via osmotic minipump. Endothelial cell function was assessed in isolated aortic rings by vascular reactivity and levels of cyclic GMP. In L-NAME-treated rabbits there was inhibition of endothelium-dependent relaxations to acetylcholine and the calcium ionophore A23187 as well as impaired cyclic GMP accumulation in response to acetylcholine. Neointima formation in the ascending thoracic aorta was assessed by determining media and intima cross-sectional areas with computerized image analysis. Compared with rabbits that consumed the cholesterol diet alone, L-NAME-treated rabbits had significant increases in lesion area (0.29 +/- 0.04 versus 0.15 +/- 0.03 mm2) and in lesion/media ratio (0.06 +/- 0.01 versus 0.03 +/- 0.01). Plasma levels of cholesterol and fluorescent lipid peroxide products were unchanged, suggesting no difference in cholesterol metabolism or oxidation. Because arterial blood pressure was not altered by L-NAME treatment, the increased atherogenesis could not be attributed to an increase in blood pressure. These results indicated that local inhibition of NO accelerates early neointima formation possibly because of modulating monocyte recruitment or foam cell lipid accumulation.
This article has been cited by other articles:
![]() |
A. GLUBA, M. BANACH, D. P. MIKHAILIDIS, and J. RYSZ Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors In Vivo, September 1, 2009; 23(5): 797 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moukdar, J. Robidoux, O. Lyght, J. Pi, K. W. Daniel, and S. Collins Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice J. Lipid Res., January 1, 2009; 50(1): 59 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, H. Chai, Z. Wang, P. H. Lin, Q. Yao, and C. Chen Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2399 - H2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wohlfart, H. Xu, A. Endlich, A. Habermeier, E. I. Closs, T. Hubschle, C. Mang, H. Strobel, T. Suzuki, H. Kleinert, et al. Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Nier, L. S. Harrington, M. J. Carrier, and P. D. Weinberg Evidence for a specific influence of the nitrergic pathway on the peripheral pulse waveform in rabbits Exp Physiol, April 1, 2008; 93(4): 503 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Steinkamp-Fenske, L. Bollinger, H. Xu, Y. Yao, S. Horke, U. Forstermann, and H. Li Reciprocal Regulation of Endothelial Nitric-Oxide Synthase and NADPH Oxidase by Betulinic Acid in Human Endothelial Cells J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 836 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, X. He, X. Chen, H. Ma, D. Liu, J. Luo, Z. Du, Y. Jin, Y. Xiong, J. He, et al. Enhanced External Counterpulsation Inhibits Intimal Hyperplasia by Modifying Shear Stress Responsive Gene Expression in Hypercholesterolemic Pigs Circulation, July 31, 2007; 116(5): 526 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramchandra, C. J. Barrett, S.-J. Guild, F. McBryde, and S. C. Malpas Role of renal sympathetic nerve activity in hypertension induced by chronic nitric oxide inhibition Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1479 - R1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, K. Witte, M. August, I. Brausch, U. Godtel-Armbrust, A. Habermeier, E. I. Closs, M. Oelze, T. Munzel, and U. Forstermann Reversal of Endothelial Nitric Oxide Synthase Uncoupling and Up-Regulation of Endothelial Nitric Oxide Synthase Expression Lowers Blood Pressure in Hypertensive Rats J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2536 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mineo, H. Deguchi, J. H. Griffin, and P. W. Shaul Endothelial and Antithrombotic Actions of HDL Circ. Res., June 9, 2006; 98(11): 1352 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jesmin, S. Zaedi, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi Effects of a Selective Endothelin A Receptor Antagonist on the Expressions of iNOS and eNOS in the Heart of Early Streptozotocin-Induced Diabetic Rats. Experimental Biology and Medicine, June 1, 2006; 231(6): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Matsui, S. Xu, K. A. Maitland, R. Mastroianni, J. A. Leopold, D. E. Handy, J. Loscalzo, and R. A. Cohen Glucose-6-Phosphate Dehydrogenase Deficiency Decreases Vascular Superoxide and Atherosclerotic Lesions in Apolipoprotein E-/- Mice Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 910 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang and X.-F. Ming Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin. Med. Res., March 1, 2006; 4(1): 53 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
S D Robinson, C A Ludlam, N A Boon, and D E Newby Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease Heart, February 1, 2006; 92(2): 170 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kerkeni, F. Addad, M. Chauffert, A. Myara, M. Ben Farhat, A. Miled, K. Maaroufi, and F. Trivin Hyperhomocysteinemia, Endothelial Nitric Oxide Synthase Polymorphism, and Risk of Coronary Artery Disease Clin. Chem., January 1, 2006; 52(1): 53 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Koebnick, A. L. Garcia, P. C. Dagnelie, C. Strassner, J. Lindemans, N. Katz, C. Leitzmann, and I. Hoffmann Long-Term Consumption of a Raw Food Diet Is Associated with Favorable Serum LDL Cholesterol and Triglycerides but Also with Elevated Plasma Homocysteine and Low Serum HDL Cholesterol in Humans,2 J. Nutr., October 1, 2005; 135(10): 2372 - 2378. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kitta, T. Nakamura, Y. Kodama, H. Takano, K. Umetani, D. Fujioka, Y. Saito, K.-i. Kawabata, J.-e. Obata, Y. Ichigi, et al. Endothelial Vasomotor Dysfunction in the Brachial Artery Is Associated With Late In-Stent Coronary Restenosis J. Am. Coll. Cardiol., August 16, 2005; 46(4): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schnabel, K. J. Lackner, H. J. Rupprecht, C. Espinola-Klein, M. Torzewski, E. Lubos, C. Bickel, F. Cambien, L. Tiret, T. Munzel, et al. Glutathione Peroxidase-1 and Homocysteine for Cardiovascular Risk Prediction: Results from the AtheroGene Study J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1631 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Scholz and W. Schaper Preconditioning of arteriogenesis Cardiovasc Res, February 1, 2005; 65(2): 513 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Raja and S. H. Nayak Sildenafil: Emerging Cardiovascular Indications Ann. Thorac. Surg., October 1, 2004; 78(4): 1496 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, N. Xia, I. Brausch, Y. Yao, and U. Forstermann Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 926 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Suda, M. Tsutsui, T. Morishita, H. Tasaki, S. Ueno, S. Nakata, T. Tsujimoto, Y. Toyohira, Y. Hayashida, Y. Sasaguri, et al. Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase-Deficient Mice: Involvement of Renin-Angiotensin System and Oxidative Stress Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1682 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vallance and J. Leiper Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1023 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weis, T. N. Kledal, K. Y. Lin, S. N. Panchal, S. Z. Gao, H. A. Valantine, E. S. Mocarski, and J. P. Cooke Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis Circulation, February 3, 2004; 109(4): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sumi and L. J. Ignarro Estrogen-related receptor {alpha}1 up-regulates endothelial nitric oxide synthase expression PNAS, November 25, 2003; 100(24): 14451 - 14456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Stuhlinger, R. K. Oka, E. E. Graf, I. Schmolzer, B. M. Upson, O. Kapoor, A. Szuba, M. R. Malinow, T. C. Wascher, O. Pachinger, et al. Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine Circulation, August 26, 2003; 108(8): 933 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Achan, M. Broadhead, M. Malaki, G. Whitley, J. Leiper, R. MacAllister, and P. Vallance Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): 1455 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Chan, P. Vallance, and H. M. Colhoun Endothelium-Dependent and -Independent Vascular Dysfunction in Type 1 Diabetes: Role of Conventional Risk Factors, Sex, and Glycemic Control Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1048 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wolfrum, K. S. Jensen, and J. K. Liao Endothelium-Dependent Effects of Statins Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mineo, I. S. Yuhanna, M. J. Quon, and P. W. Shaul High Density Lipoprotein-induced Endothelial Nitric-oxide Synthase Activation Is Mediated by Akt and MAP Kinases J. Biol. Chem., March 7, 2003; 278(11): 9142 - 9149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Colombo, U. Paradossi, M. G. Andreassi, N. Botto, S. Manfredi, S. Masetti, A. Biagini, and A. Clerico Endothelial Nitric Oxide Synthase Gene Polymorphisms and Risk of Coronary Artery Disease Clin. Chem., March 1, 2003; 49(3): 389 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W Shaul Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis J. Physiol., February 15, 2003; 547(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Warnholtz, H. Mollnau, T. Heitzer, A. Kontush, T. Moller-Bertram, D. Lavall, A. Giaid, U. Beisiegel, S. L. Marklund, U. Walter, et al. Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1356 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Suda, M. Tsutsui, T. Morishita, A. Tanimoto, M. Horiuchi, H. Tasaki, P. L. Huang, Y. Sasaguri, N. Yanagihara, and Y. Nakashima Long-Term Treatment With N{omega}-Nitro-L-Arginine Methyl Ester Causes Arteriosclerotic Coronary Lesions in Endothelial Nitric Oxide Synthase-Deficient Mice Circulation, September 24, 2002; 106(13): 1729 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sanada, K. Node, H. Asanuma, H. Ogita, S. Takashima, T. Minamino, M. Asakura, Y. Liao, A. Ogai, J. Kim, et al. Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: Role of 70-kDa S6 kinase and extracellular signal-regulated kinase J. Am. Coll. Cardiol., September 4, 2002; 40(5): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vita and J. Loscalzo Shouldering the Risk Factor Burden: Infection, Atherosclerosis, and the Vascular Endothelium Circulation, July 9, 2002; 106(2): 164 - 166. [Full Text] [PDF] |
||||
![]() |
C.P.M. Leeson, A.D. Hingorani, M.J. Mullen, N. Jeerooburkhan, M. Kattenhorn, T.J. Cole, D.P.R. Muller, A. Lucas, S.E. Humphries, and J.E. Deanfield Glu298Asp Endothelial Nitric Oxide Synthase Gene Polymorphism Interacts With Environmental and Dietary Factors to Influence Endothelial Function Circ. Res., June 14, 2002; 90(11): 1153 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
M G Colombo, M G Andreassi, U Paradossi, N Botto, S Manfredi, S Masetti, G Rossi, A Clerico, and A Biagini Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298->Asp polymorphism) to the presence, extent, and severity of coronary artery disease Heart, June 1, 2002; 87(6): 525 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Rajamannan, M. J. Springett, L. G. Pederson, and S. W. Carmichael Localization of Caveolin 1 in Aortic Valve Endothelial Cells Using Antigen Retrieval J. Histochem. Cytochem., May 1, 2002; 50(5): 617 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. MINEO and P.W. SHAUL Modulation of Endothelial NO Production by High-density Lipoprotein Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 459 - 470. [Abstract] [PDF] |
||||
![]() |
M. D. Savvidou, P. J.T. Vallance, K. H. Nicolaides, and A. D. Hingorani Endothelial Nitric Oxide Synthase Gene Polymorphism and Maternal Vascular Adaptation to Pregnancy Hypertension, December 1, 2001; 38(6): 1289 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Stuhlinger, P. S. Tsao, J.-H. Her, M. Kimoto, R. F. Balint, and J. P. Cooke Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine Circulation, November 20, 2001; 104(21): 2569 - 2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imamura, S. Biro, T. Kihara, S. Yoshifuku, K. Takasaki, Y. Otsuji, S. Minagoe, Y. Toyama, and C. Tei Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1083 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saitta, D. Altavilla, D. Cucinotta, N. Morabito, N. Frisina, F. Corrado, R. D'Anna, A. Lasco, G. Squadrito, A. Gaudio, et al. Randomized, Double-Blind, Placebo-Controlled Study on Effects of Raloxifene and Hormone Replacement Therapy on Plasma NO Concentrations, Endothelin-1 Levels, and Endothelium-Dependent Vasodilation in Postmenopausal Women Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1512 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Setoguchi, M. Mohri, H. Shimokawa, and A. Takeshita Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease J. Am. Coll. Cardiol., August 1, 2001; 38(2): 493 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. John, C. Delles, J. Jacobi, M. P. Schlaich, M. Schneider, G. Schmitz, and R. E. Schmieder Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1351 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vallance and N. Chan GENERAL CARDIOLOGY: Endothelial function and nitric oxide: clinical relevance Heart, March 1, 2001; 85(3): 342 - 350. [Full Text] |
||||
![]() |
X.-L. Niu, X. Yang, K. Hoshiai, K. Tanaka, S. Sawamura, Y. Koga, and H. Nakazawa Inducible Nitric Oxide Synthase Deficiency Does Not Affect the Susceptibility of Mice to Atherosclerosis but Increases Collagen Content in Lesions Circulation, February 27, 2001; 103(8): 1115 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Raij Workshop: Hypertension and Cardiovascular Risk Factors : Role of the Angiotensin II-Nitric Oxide Interaction Hypertension, February 1, 2001; 37(2): 767 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. O'Donnell and B. A. Freeman Interactions Between Nitric Oxide and Lipid Oxidation Pathways : Implications for Vascular Disease Circ. Res., January 19, 2001; 88(1): 12 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Walker, T. S. Dean, T. A. B. Sanders, G. Jackson, J. M. Ritter, and P. J. Chowienczyk The Phytoestrogen Genistein Produces Acute Nitric Oxide-Dependent Dilation of Human Forearm Vasculature With Similar Potency to 17{beta}-Estradiol Circulation, January 16, 2001; 103(2): 258 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Boger, S. M. Bode-Boger, P. S. Tsao, P. S. Lin, J. R. Chan, and J. P. Cooke An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2287 - 2295. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Knowles and N. Maeda Genetic Modifiers of Atherosclerosis in Mice Arterioscler Thromb Vasc Biol, November 1, 2000; 20(11): 2336 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Cooke Does ADMA Cause Endothelial Dysfunction? Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2032 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability Cardiovasc Res, September 1, 2000; 47(4): 648 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Behr-Roussel, A. Rupin, S. Simonet, E. Bonhomme, S. Coumailleau, A. Cordi, B. Serkiz, J.-N. Fabiani, and T. J. Verbeuren Effect of Chronic Treatment With the Inducible Nitric Oxide Synthase Inhibitor N-Iminoethyl-L-Lysine or With L-Arginine on Progression of Coronary and Aortic Atherosclerosis in Hypercholesterolemic Rabbits Circulation, August 29, 2000; 102(9): 1033 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Patel, A.-L. Levonen, J. H. Crawford, and V. M. Darley-Usmar Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis Cardiovasc Res, August 18, 2000; 47(3): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyao, K. Kugiyama, H. Kawano, T. Motoyama, H. Ogawa, M. Yoshimura, T. Sakamoto, and H. Yasue Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina J. Am. Coll. Cardiol., August 1, 2000; 36(2): 432 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Channon, H. Qian, and S. E. George Nitric Oxide Synthase in Atherosclerosis and Vascular Injury : Insights From Experimental Gene Therapy Arterioscler Thromb Vasc Biol, August 1, 2000; 20(8): 1873 - 1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bloodsworth, V. B. O'Donnell, and B. A. Freeman Nitric Oxide Regulation of Free Radical- and Enzyme-Mediated Lipid and Lipoprotein Oxidation Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1707 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elbaz, O. Poirier, T. Moulin, F. Chedru, F. Cambien, and P. Amarenco Association Between the Glu298Asp Polymorphism in the Endothelial Constitutive Nitric Oxide Synthase Gene and Brain Infarction Stroke, July 1, 2000; 31(7): 1634 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R Andersen and S. Stender Endothelial nitric oxide synthase activity in aorta of normocholesterolemic rabbits: regional variation and the effect of estrogen Cardiovasc Res, July 1, 2000; 47(1): 192 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kauser, V. da Cunha, R. Fitch, C. Mallari, and G. M. Rubanyi Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1679 - H1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Uittenbogaard, P. W. Shaul, I. S. Yuhanna, A. Blair, and E. J. Smart High Density Lipoprotein Prevents Oxidized Low Density Lipoprotein-induced Inhibition of Endothelial Nitric-oxide Synthase Localization and Activation in Caveolae J. Biol. Chem., April 6, 2000; 275(15): 11278 - 11283. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orlandi, M. Marcellini, and L. G. Spagnoli Aging Influences Development and Progression of Early Aortic Atherosclerotic Lesions in Cholesterol-Fed Rabbits Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1123 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li and U. Förstermann Structure-Activity Relationship of Staurosporine Analogs in Regulating Expression of Endothelial Nitric-Oxide Synthase Gene Mol. Pharmacol., March 1, 2000; 57(3): 427 - 435. [Abstract] [Full Text] |
||||
![]() |
Y.-X. Wang, M. Halks-Miller, R. Vergona, M. E. Sullivan, R. Fitch, C. Mallari, B. Martin-McNulty, V. da Cunha, A. Freay, G. M. Rubanyi, et al. Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H428 - H434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blair, P. W. Shaul, I. S. Yuhanna, P. A. Conrad, and E. J. Smart Oxidized Low Density Lipoprotein Displaces Endothelial Nitric-oxide Synthase (eNOS) from Plasmalemmal Caveolae and Impairs eNOS Activation J. Biol. Chem., November 5, 1999; 274(45): 32512 - 32519. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marano, S. Palazzesi, A. Vergari, and A. U. Ferrari Protection by Shear Stress From Collar-Induced Intimal Thickening : Role of Nitric Oxide Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2609 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bundy, N. Marczin, A. H. Chester, and M. Yacoub Differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1799 - H1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Hingorani, C. F. Liang, J. Fatibene, A. Lyon, S. Monteith, A. Parsons, S. Haydock, R. V. Hopper, N. G. Stephens, K. M. O'Shaughnessy, et al. A Common Variant of the Endothelial Nitric Oxide Synthase (Glu298->Asp) Is a Major Risk Factor for Coronary Artery Disease in the UK Circulation, October 5, 1999; 100(14): 1515 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang, M. Haverty, and P. Brecher N-Acetyl-L-Cysteine Enhances Interleukin-1{beta}-Induced Nitric Oxide Synthase Expression Hypertension, October 1, 1999; 34(4): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ono, H. Ono, H. Matsuoka, T. Fujimori, and E. D. Frohlich Apoptosis, Coronary Arterial Remodeling, and Myocardial Infarction After Nitric Oxide Inhibition in SHR Hypertension, October 1, 1999; 34(4): 609 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Stein, J. G. Keevil, D. A. Wiebe, S. Aeschlimann, and J. D. Folts Purple Grape Juice Improves Endothelial Function and Reduces the Susceptibility of LDL Cholesterol to Oxidation in Patients With Coronary Artery Disease Circulation, September 7, 1999; 100(10): 1050 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Leiper and P. Vallance Biological significance of endogenous methylarginines that inhibit nitric oxide synthases Cardiovasc Res, August 15, 1999; 43(3): 542 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Linz, P. Wohlfart, B. A Scholkens, T. Malinski, and G. Wiemer Interactions among ACE, kinins and NO Cardiovasc Res, August 15, 1999; 43(3): 549 - 561. [Full Text] [PDF] |
||||
![]() |
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF] |
||||
![]() |
I. Six, E. Van Belle, R. Bordet, D. Corseaux, J. Callebert, B. Dupuis, C. Bauters, and M. E. Bertrand L-Arginine and L-NAME have no effects on the reendothelialization process after arterial balloon injury Cardiovasc Res, August 15, 1999; 43(3): 731 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. O'Donnell, K. B. Taylor, S. Parthasarathy, H. Kuhn, D. Koesling, A. Friebe, A. Bloodsworth, V. M. Darley-Usmar, and B. A. Freeman 15-Lipoxygenase Catalytically Consumes Nitric Oxide and Impairs Activation of Guanylate Cyclase J. Biol. Chem., July 16, 1999; 274(29): 20083 - 20091. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qian, V. Neplioueva, G. A. Shetty, K. M. Channon, and S. E. George Nitric Oxide Synthase Gene Therapy Rapidly Reduces Adhesion Molecule Expression and Inflammatory Cell Infiltration in Carotid Arteries of Cholesterol-Fed Rabbits Circulation, June 15, 1999; 99(23): 2979 - 2982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Cooke The 1998 Nobel prize in Medicine: clinical implications for 1999 and beyond Vascular Medicine, May 1, 1999; 4(2): 57 - 60. [PDF] |
||||
![]() |
C. A. D. Nascimento, K. Kauser, and G. M. Rubanyi Effect of 17beta -estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1788 - H1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyazaki, H. Matsuoka, J. P. Cooke, M. Usui, S. Ueda, S. Okuda, and T. Imaizumi Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis Circulation, March 9, 1999; 99(9): 1141 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Le Tourneau, E. Van Belle, D. Corseaux, B. Vallet, G. Lebuffe, B. Dupuis, J.-M. Lablanche, E. McFadden, C. Bauters, and M. E. Bertrand Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling J. Am. Coll. Cardiol., March 1, 1999; 33(3): 876 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bosmans, C. J. Vrints, M. M. Kockx, H. Bult, K. M. C. Cromheeke, and A. G. Herman Continuous Perivascular L-Arginine Delivery Increases Total Vessel Area and Reduces Neointimal Thickening After Experimental Balloon Dilatation Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 767 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. KIELSTEIN, R. H. BÖGER, S. M. BODE-BÖGER, J. SCHÄFFER, M. BARBEY, K. M. KOCH, and J. C. FRÖLICH Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End-Stage Renal Disease: Relationship to Treatment Method andAtherosclerotic Disease J. Am. Soc. Nephrol., March 1, 1999; 10(3): 594 - 600. [Abstract] [Full Text] |
||||
![]() |
C. Depre, X. Havaux, J. Renkin, J. L. J. Vanoverschelde, and W. Wijns Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque Cardiovasc Res, February 1, 1999; 41(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Makaritsis, H. Gavras, Y. Du, A. V. Chobanian, and P. Brecher {alpha}1-Adrenergic Plus Angiotensin Receptor Blockade Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice Hypertension, December 1, 1998; 32(6): 1044 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barton, C. C. Haudenschild, L. V. d'Uscio, S. Shaw, K. Munter, and T. F. Luscher Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice PNAS, November 24, 1998; 95(24): 14367 - 14372. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Boger, S. M. Bode-Boger, A. Szuba, P. S. Tsao, J. R. Chan, O. Tangphao, T. F. Blaschke, and J. P. Cooke Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction : Its Role in Hypercholesterolemia Circulation, November 3, 1998; 98(18): 1842 - 1847. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hibi, T. Ishigami, K. Tamura, S. Mizushima, N. Nyui, T. Fujita, H. Ochiai, M. Kosuge, Y. Watanabe, Y. Yoshii, et al. Endothelial Nitric Oxide Synthase Gene Polymorphism and Acute Myocardial Infarction Hypertension, September 1, 1998; 32(3): 521 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Usui, T. Ichiki, M. Katoh, K. Egashira, and A. Takeshita Regulation of Angiotensin II Receptor Expression by Nitric Oxide in Rat Adrenal Gland Hypertension, September 1, 1998; 32(3): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vasquez-Vivar, B. Kalyanaraman, P. Martasek, N. Hogg, B. S. S. Masters, H. Karoui, P. Tordo, and K. A. Pritchard Jr. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors PNAS, August 4, 1998; 95(16): 9220 - 9225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Liao Endothelium and acute coronary syndromes Clin. Chem., August 1, 1998; 44(8): 1799 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Scalia, J. Z. Appel III, and A. M. Lefer Leukocyte-Endothelium Interaction During the Early Stages of Hypercholesterolemia in the Rabbit : Role of P-Selectin, ICAM-1, and VCAM-1 Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ravalli, A. Albala, M. Ming, M. Szabolcs, A. Barbone, R. E. Michler, and P. J. Cannon Inducible Nitric Oxide Synthase Expression in Smooth Muscle Cells and Macrophages of Human Transplant Coronary Artery Disease Circulation, June 16, 1998; 97(23): 2338 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Myers and M. A. Tanner Vascular Endothelial Cell Regulation of Extracellular Matrix Collagen : Role of Nitric Oxide Arterioscler Thromb Vasc Biol, May 1, 1998; 18(5): 717 - 722. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |